Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 193.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000219 (2002)	J F Gagnon [Canada] ; J. Montplaisir ; M A Bédard	[Rapid-eye-movement sleep disorders in Parkinson's disease].
000230 (2002)	Oksana Suchowersky [Canada]	Parkinson's disease: medical treatment of moderate to advanced disease.
000255 (2002)	R. Levy [Canada] ; A E Lang ; W D Hutchison ; A M Lozano ; J O Dostrovsky	Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's disease.
000272 (2003)	Michael Iskedjian [Canada] ; Thomas R. Einarson	Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.
000275 (2003)	Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl	Leg muscle strength is reduced in PD and relates to the ability to rise from a chair
000281 (2003)	J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B Calne	Familial and sporadic Parkinson's disease usually display the same clinical features.
000282 (2003)	B C L. Lai [Canada] ; M. Schulzer ; S. Marion ; K. Teschke ; J K C. Tsui	The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
000284 (2003)	Frédéric Calon [Canada] ; Marc Morissette ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
000294 (2003)	W R Wayne Martin [Canada] ; Marguerite Wieler	Treatment of Parkinson's disease.
000308 (2003)	D. Coyle [Canada] ; M. Barbeau ; M. Guttman ; J-F Baladi	The economic evaluation of pharmacotherapies for Parkinson's disease.
000322 (2003)	Ajit Kumar [Canada] ; Sharanpal Mann ; Vesna Sossi ; Thomas J. Ruth ; A Jon Stoessl ; Michael Schulzer ; Chong S. Lee	[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
000326 (2003)	A Jon Stoessl [Canada]	Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
000332 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000354 (2004)	Yoshiaki Furukawa [Canada]	Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
000364 (2003)	Susan M. Calne [Canada] ; Ajit Kumar	Nursing care of patients with late-stage Parkinson's disease.
000396 (2004)	Connie Marras [Canada] ; Anthony Lang ; Murray Krahn ; George Tomlinson ; Gary Naglie	Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
000405 (2004)	Harold D. Foster [Canada] ; Abram Hoffer	The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
000414 (2004)	Alexander Rajput [Canada] ; Christopher A. Robinson ; Ali H. Rajput	Essential tremor course and disability: A clinicopathologic study of 20 cases.
000421 (2004)	Anthony E. Lang [Canada] ; Jose A. Obeso	Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
000439 (2004)	Alan L. Whone [Royaume-Uni] ; Dale L. Bailey ; Philippe Remy ; Nicola Pavese ; David J. Brooks	A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
000447 (2004)	Tom H. Johnston [Canada] ; Jonathan M. Brotchie	Drugs in development for Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022